Clinical Trial

A Study in Adults With Desmoid Tumors

Name: A Study in Adults With Desmoid Tumors — clinical trial record (NCT07541430)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is an open-label, multicenter, single-arm phase 2 clinical study designed to evaluate the efficacy, safety, tolerability, patient-reported outcomes (PROs), pharmacokinetics (PK), anti-drug antibody (ADA) and pharmacodynamics (PD) of ES014 in adult desmoid tumor patients.

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-01

Trial Details

NCT Number	NCT07541430
Lead Sponsor	Elpiscience (Suzhou) Biopharma, Ltd.
Conditions	Desmoid Tumor
Enrollment	50 participants
Start Date	2026-04-30
Primary Completion	2028-01 (estimated)
Study Completion	2028-10 (estimated)
Updated on ClinicalTrials.gov	2026-04-30